Vext Science, Inc.
VEXT
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.30% | -11.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.30% | -11.42% | |||
| Cost of Revenue | -18.44% | -36.15% | |||
| Gross Profit | 21.49% | 65.71% | |||
| SG&A Expenses | 9.70% | -38.85% | |||
| Depreciation & Amortization | -0.07% | 364.73% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.79% | -26.69% | |||
| Operating Income | -- | 100.00% | |||
| Income Before Tax | 89.74% | 92.90% | |||
| Income Tax Expenses | 0.00% | -83.44% | |||
| Earnings from Continuing Operations | 64.69% | 91.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 64.69% | 91.55% | |||
| EBIT | -- | 100.00% | |||
| EBITDA | 22.20% | 316.31% | |||
| EPS Basic | 63.89% | 91.55% | |||
| Normalized Basic EPS | 107.69% | 77.59% | |||
| EPS Diluted | 63.89% | 91.57% | |||
| Normalized Diluted EPS | 107.69% | 77.59% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||